Hostname: page-component-6d856f89d9-26vmc Total loading time: 0 Render date: 2024-07-16T06:02:01.400Z Has data issue: false hasContentIssue false

Cognitive therapy and social functioning in chronic depression

Published online by Cambridge University Press:  02 January 2018

S. Ito
Affiliation:
Department of Psychiatry, Nagoya City University Medical School, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © 2001 The Royal College of Psychiatrists 

We clinicians constantly encounter patients with major depression in partial remission. They are no longer acutely depressed but continue to present with substantial functional impairment (Reference Paykel, Ramana and CooperPaykel et al, 1995). For treatment-resistant depression, only one pharmacological intervention can be recommended today with reasonable evidence, namely lithium augmentation (Reference Austin, Souza and GoodwinAustin et al, 1991; Reference Aronson, Offman and JoffeAronson et al, 1996), but this may not be the answer for those with low-grade residual depression.

Scott et al (Reference Scott, Teasdale and Paykel2000) demonstrated that cognitive therapy can help these people. Critically appraising their article in our evidence-based psychiatry case conference, however, it was very difficult for us to appreciate the substantive significance of this improvement, because only means and standard deviations of scores on the Social Adjustment Scale were reported. Analyses based on these data can show whether or not the treatment is better than the control condition, but cannot show how much better it is - a crucial piece of information for both patients and clinicians. We therefore resorted to the normative data for this scale (Reference Bothwell and WeissmanBothwell & Weissman, 1977). Calculation based on the means and standard deviations under the assumption of a normal distribution showed that, at week 20, 68% of patients with residual depression reached the 95% range of the control subjects when treated with clinical management plus cognitive therapy, whereas only 45% did so when treated with clinical management only. This translates into a ‘number needed to treat’ of 4.4 (95% CI 2.6-12.6).

This is an impressive figure. By adding 16 sessions of cognitive therapy to usual care, we can achieve social remission in one additional patient out of four, compared with continued standard care only. The original authors had concluded, “In patients showing only partial response to antidepressants, the addition of CT produced modest improvement in social and psychological functioning”. We find that the improvement was more than modest and would be clinically meaningful.

References

Aronson, R., Offman, H. J., Joffe, R. T., et al (1996) Triiodothyronine augmentation in the treatment of refractory depression: a meta-analysis. Archives of General Psychiatry, 53, 842848.CrossRefGoogle ScholarPubMed
Austin, M.-P. V., Souza, F. G. M. & Goodwin, G. M. (1991) Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. British Journal of Psychiatry, 159, 510514.Google Scholar
Bothwell, S. & Weissman, M. M. (1977) Social impairments four years after an acute depressive episode. American Journal of Orthopsychiatry, 47, 231237.Google Scholar
Paykel, E. S., Ramana, R., Cooper, Z., et al (1995) Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine, 25, 11711180.Google Scholar
Scott, J., Teasdale, J. D., Paykel, E. S., et al (2000) Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. British Journal of Psychiatry, 177, 440446.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.